Biblio

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

G

Chen J, Tan J, Li J, Cheng W, Ke L, Wang A, Wang Q, Lin S, Li G, Wang B, et al. Genetically Engineered Biomimetic Nanoparticles for Targeted Delivery of mRNA to Treat Rheumatoid Arthritis. Small Methods. 2023:e2300678.

Oelsner S, Waldmann A, Billmeier A, Röder J, Lindner A, Ullrich E, Marschalek R, Dotti G, Jung G, Große-Hovest L, et al. Genetically engineered CAR NK cells display selective cytotoxicity against FLT3-positive B-ALL and inhibit in vivo leukemia growth. Int J Cancer. 2019.

Zhou Y-Q, Shi Y, Yang L, Sun Y-F, Han Y-F, Zhao Z-X, Wang Y-J, Liu Y, Ma Y, Zhang T, et al. Genetically engineered distal airway stem cell transplantation protects mice from pulmonary infection. EMBO Mol Med. 2019:e10233.

Zheng R, Liu X, Abdollahi E, Tavasolian F. Genetically Engineered Exosomes as a Potential Regulator of Th1 Cells Response in Rheumatoid Arthritis. Biopreserv Biobank. 2023.

Li D, Zhu Y, Yang T, Yang M, Mao C. Genetically Engineered Flagella Form Collagen-like Ordered Structures for Inducing Stem Cell Differentiation. iScience. 2019;17:277-287.

Mallick S, Chakrabarti J, Eschbacher J, Moraitis AG, Greenstein AE, Churko J, Pond KW, Livolsi A, Thorne C, Little AS, et al. GENETICALLY ENGINEERED HUMAN PITUITARY CORTICOTROPH TUMOR ORGANOIDS EXHIBIT DIVERGENT RESPONSES TO GLUCOCORTICOID RECEPTOR MODULATORS. Transl Res. 2023.

Goh JJ, Ong HT, Lee BS, Teoh HK. Genetically engineered human umbilical cord-derived mesenchymal stem cells expressing human interleukin-12 and in vitro growth inhibition against lung adenocarcinoma cells. Malays J Pathol. 2023;45(2):247-259.

Verheyen A, Diels A, Reumers J, Van Hoorde K, Van Den Wyngaert I, d'Ydewalle Cvan Outryv, De Bondt A, Kuijlaars J, De Muynck L, De Hoogt R, et al. Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes. Stem Cell Reports. 2019;13(2):434-435.

Rostami M, Haidari K, Amini H, Shahbazi M. Genetically Engineered Mesenchymal Stem Cell Therapy Against Murine Experimental Autoimmune Encephalomyelitis. Mol Neurobiol. 2022.

Hwang BWoo, Kim SJin, Park KMin, Kim H, Yeom J, Yang J-A, Jeong H, Jung H, Kim K, Sung YChul, et al. Genetically engineered mesenchymal stem cell therapy using self-assembling supramolecular hydrogels. J Control Release. 2015.

Huang H, Qian M, Liu Y, Chen S, Li H, Han Z, Han Z-C, Chen X, Zhao Q, Li Z. Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy. Elife. 2023;12.

Li J, Li N, Wei J, Feng C, Chen Y, Chen T, Ai Z, Zhu X, Ji W, Li T. Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson's disease in animal models. NPJ Parkinsons Dis. 2022;8(1):175.

Mahmoudian RAlsadat, Farshchian M, Abbaszadegan MReza. Genetically Engineered Mouse Models of Esophageal Cancer. Exp Cell Res. 2021:112757.

Kaczanowska S, Beury DW, Gopalan V, Tycko AK, Qin H, Clements ME, Drake J, Nwanze C, Murgai M, Rae Z, et al. Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis. Cell. 2021.

Pan Y, Yu L, Liu L, Zhang J, Liang S, Parshad B, Lai J, Ma L-M, Wang Z, Rao L. Genetically engineered nanomodulators elicit potent immunity against cancer stem cells by checkpoint blockade and hypoxia relief. Bioact Mater. 2024;38:31-44.

Ismaeel GLutfi, AlHassani OJabbar Mak, Alazragi RS, Ahmed AHussein, Mohamed A'aH, Jasim NYasir, Shari FHassan, Almashhadani HAbdulkaree. Genetically engineered neural stem cells (NSCs) therapy for neurological diseases; state-of-the-art. Biotechnol Prog. 2023:e3363.

Hamade DF, Epperly MW, Fisher R, Hou W, Shields D, van Pijkeren J-P, Leibowitz BJ, Coffman LG, Wang H, M Huq S, et al. Genetically Engineered Probiotic Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer. Cancers (Basel). 2024;16(3).

Wenzel M, Aquadro CF. genetically interacts with the germline stem cell gene in male . MicroPubl Biol. 2023;2023.

Mundra V, Wu H, Mahato RI. Genetically modified human bone marrow derived mesenchymal stem cells for improving the outcome of human islet transplantation. PLoS One. 2013;8(10):e77591.

Kumagai G, Tsoulfas P, Toh S, McNiece I, Bramlett HM, W Dietrich D. Genetically Modified Mesenchymal Stem Cells (MSCs) promote axonal regeneration and prevent hypersensitivity after Spinal Cord Injury. Exp Neurol. 2013.

Bahrambeigi V, Ahmadi N, Salehi R, Javanmard SHaghjooy. Genetically Modified Murine Adipose-Derived Mesenchymal Stem Cells Producing Interleukin-2 Favors B16F10 Melanoma Cell Proliferation. Immunol Invest. 2015:1-21.

Jung G, Sun J, Petrowitz B, Riecken K, Kruszewski K, Jankowiak W, Kunst F, Skevas C, Richard G, Fehse B, et al. Genetically Modified Neural Stem Cells for a Local and Sustained Delivery of Neuroprotective Factors to the Dystrophic Mouse Retina. Stem Cells Transl Med. 2013.

Wang X, Liu T-X, Zhang Y, Xu L-W, Yuan S-L, Cui A-L, Guo W-W, Wang Y-F, Yang S-M, Zhao J-G. Genetically modified pigs: Emerging animal models for hereditary hearing loss. Zool Res. 2024;45(2):284-291.

Price CJ, Stavish D, Gokhale PJ, Stevenson BA, Sargeant S, Lacey J, Rodríguez TA, Barbaric I. Genetically variant human pluripotent stem cells selectively eliminate wild-type counterparts through YAP-mediated cell competition. Dev Cell. 2021.

Teque F, Ye L, Xie F, Wang J, Morvan MG, Kan YWai, Levy JA. Genetically-edited iPSCs derived from HIV-1 infected patients on therapy can give rise to immune cells resistant to HIV-1 infection. AIDS. 2020.

Pages